Bone Biologics Corp (BBLG) stock
BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.28−0.02 (-5.46%)
Close on Nov 19, 2026Market cap $932.33KP/E –Yield –
Bone Biologics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Bone Biologics's revenue for the twelve months ending Jun 30, 2021 was $1.07B. For fiscal 2020 it was $1.07B, up 0.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $1.07B | 0.0% |
| FY2019 | Dec 31, 2019 | $1.07B | 0.0% |
| FY2016 | Dec 31, 2016 | $1.07B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q1 FY2021 | Mar 31, 2021 | $1.07B | 0.0% |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $1.07B | – |
See a number that looks wrong?